Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Researchers identify molecular characteristics of leptomeningeal melanoma metastases
Patients with advanced melanoma who develop metastases in the leptomeninges, the fluid filled membranes surrounding…
Researchers decipher a new way that immune cells detect infections and cancers
Published in Science, the research team from the Peter Doherty Institute for Infection and Immunity (Doherty…
Pancreatic cancer cells secrete signal that sabotages immune attack on tumours
A key immune signal has a previously unknown role in turning off the immune system’s…
Big Pharma, my cancer patient and me
Source: Guardian – Ranjana Srivastava. My patient was refused compassionate access to a cheap chemotherapy. Why? Because pharmaceutical companies are often…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.